Paxlovid 150-100 MG (moderate) UU 20S
Ended Awarded Last action
- Contract number
- SPE2DR26FCW3D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,185
Award facts
- Contract value 100% obligated
- $12,185.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Paxlovid 150-100 mg (moderate) in quantities of 20 units, with a ceiling value of $12,185.38. This firm fixed price delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company holds extensive federal contract awards with the DLA Medical Supply Chain, supplying a comprehensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This award of Paxlovid, an antiviral treatment for moderate COVID-19 cases, supports the Defense Health Agency's pharmaceutical supply requirements and demonstrates AmerisourceBergen's continued role as a prime vendor for critical federal medical commodities.
Quick answers
Who was awarded contract SPE2DR26FCW3D?
SPE2DR26FCW3D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FCW3D worth?
The government has obligated $12,185 on SPE2DR26FCW3D.
Is contract SPE2DR26FCW3D an order under another contract?
Yes. SPE2DR26FCW3D is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW3D competed?
The extent of competition for SPE2DR26FCW3D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award